{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:19:36Z","timestamp":1785860376807,"version":"3.56.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"52","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,26]]},"abstract":"<jats:p>\n                    The increasing incidence and mortality of thyroid cancer (THCA) exacerbates the global cancer burden. Glutamine metabolism is a hallmark metabolic feature of tumors, but its impact on the pathogenesis and progression of THCA remains unclear. Studies retrieved THCA data from TCGA and GEO databases. Cluster analysis, differential expression analysis, and weighted gene co-expression network analysis were used to identify key glutamine metabolism-related genes (GMRGs) in THCA. Identification of key genes through protein-protein interaction network construction, based on expression and diagnosis of internal and external datasets. Their functional role was systematically evaluated by competitive endogenous RNA network analysis, genomic alteration analysis, immune-related studies, and immune checkpoint analysis. Using GMRGs and differentially expressed genes in THCA, 6 markers (NOS2, OTC, NOS1, GLS2, UCP2, RIMKLA) were selected as references for THCA clustering. Differential analysis combined with weighted gene co-expression network analysis identified 173 GMRGs in THCA. The CytoHubba algorithm in the protein-protein interaction network identified 4 hub genes: MUC1, KIT, COMP, and MMP7. Subsequent validation showed a significant decrease in the expression of KIT in tumor samples (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt; .05). Receiver operating characteristic curve (ROC) analysis showed excellent diagnostic performance with area under the curve values of 0.925, 0.945, 0.965, and 0.996 in the internal and external validation cohorts. Notably, KIT expression showed a significant difference between T and N phases (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). In addition, we delineate a regulatory network of competitive endogenous RNAs that control KIT expression. Genomic alteration analysis reveals frequent KIT modifications in anaplastic thyroid carcinoma. Tumors with low KIT expression exhibited enhanced immune infiltration and significant correlation with immune checkpoint genes, including PDCD1LG2 and PDCD1 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). This study identifies KIT as a key GMRG in THCA, positioning it as a novel diagnostic biomarker and a potential therapeutic evaluation marker for tumor progression.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000046769","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T21:01:49Z","timestamp":1766782909000},"page":"e46769","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive bioinformatics analysis identified and validated KIT as a key gene associated with glutamine metabolism in thyroid carcinoma"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3046-054X","authenticated-orcid":false,"given":"Xinxiong","family":"Li","sequence":"first","affiliation":[{"name":"Thyroid and Hernia Surgery Department, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhen","family":"Qiu","sequence":"additional","affiliation":[{"name":"Thyroid and Hernia Surgery Department, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enyu","family":"Gu","sequence":"additional","affiliation":[{"name":"Thyroid and Hernia Surgery Department, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naizhuo","family":"Ke","sequence":"additional","affiliation":[{"name":"Thyroid and Hernia Surgery Department, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0701-1150","authenticated-orcid":false,"given":"Miao","family":"Fang","sequence":"additional","affiliation":[{"name":"Thyroid and Hernia Surgery Department, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20251226","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20251226","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.33549\/physiolres.935433","article-title":"Type 2 diabetes, obesity and their relation to the risks of thyroid cancer.","volume":"73","author":"Grimmichov\u00e1","year":"2024","journal-title":"Physiol Res"},{"key":"R3-20251226","doi-asserted-by":"crossref","first-page":"101705","DOI":"10.1016\/j.ando.2025.101705","article-title":"Natural history of medullary thyroid carcinoma in MEN 2 patients carrying a variant at codon 804 in the RET proto-oncogene: a study by the french neuroendocrine tumor group (GTE).","volume":"86","author":"Suteau","year":"2025","journal-title":"Ann Endocrinol (Paris)"},{"key":"R4-20251226","doi-asserted-by":"crossref","first-page":"101678","DOI":"10.1016\/j.beem.2022.101678","article-title":"Anaplastic thyroid cancer: an update.","volume":"37","author":"Rao","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R5-20251226","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijsu.2018.07.013","article-title":"The association between thyroid cancer and insulin resistance, metabolic syndrome and its components: a systematic review and meta-analysis.","volume":"57","author":"Yin","year":"2018","journal-title":"Int J Surg"},{"key":"R6-20251226","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s40618-023-02294-y","article-title":"Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer.","volume":"47","author":"Zhang","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"R7-20251226","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12020-023-03427-2","article-title":"Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer.","volume":"82","author":"Goksoy Solak","year":"2023","journal-title":"Endocrine"},{"key":"R8-20251226","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discovery"},{"key":"R9-20251226","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells.","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"R10-20251226","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression.","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol"},{"key":"R11-20251226","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles.","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"R12-20251226","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data.","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"R13-20251226","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1186\/s12885-025-14123-x","article-title":"Integrating transcriptomic and metabolomic analyses to characterize the potential function of SLC1A5 in thyroid cancer.","volume":"25","author":"Shan","year":"2025","journal-title":"BMC Cancer"},{"key":"R14-20251226","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/cas.70039","article-title":"GGCT inhibits ferroptosis in PTC cells by upregulating p53 through RPS15A.","volume":"116","author":"Zhang","year":"2025","journal-title":"Cancer Sci"},{"key":"R15-20251226","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41419-023-05981-z","article-title":"STAG2 inactivation reprograms glutamine metabolism of BRAF-mutant thyroid cancer cells.","volume":"14","author":"Li","year":"2023","journal-title":"Cell Death Dis"},{"key":"R16-20251226","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/(SICI)1097-0215(19960328)66:1<55::AID-IJC10>3.0.CO;2-A","article-title":"Preoperative diagnosis of thyroid papillary carcinoma by reverse transcriptase polymerase chain reaction of the MUC1 gene.","volume":"66","author":"Weiss","year":"1996","journal-title":"Int J Cancer"},{"key":"R17-20251226","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1023039230052","article-title":"MT1-MMP and MMP-7 in invasion and metastasis of human cancers.","volume":"22","author":"Shiomi","year":"2003","journal-title":"Cancer Metastasis Rev"},{"key":"R18-20251226","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1158\/0008-5472.CAN-03-1460","article-title":"Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker.","volume":"64","author":"Wreesmann","year":"2004","journal-title":"Cancer Res"},{"key":"R19-20251226","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10585-011-9430-8","article-title":"Down-regulation of matrix metalloproteinase-7 inhibits metastasis of human anaplastic thyroid cancer cell line.","volume":"29","author":"Chen","year":"2012","journal-title":"Clin Exp Metastasis"},{"key":"R20-20251226","doi-asserted-by":"crossref","first-page":"115473","DOI":"10.1016\/j.ejca.2025.115473","article-title":"Adjuvant treatment of gastrointestinal stromal tumor: State of the art in 2025.","volume":"222","author":"Penel","year":"2025","journal-title":"Eur J Cancer"},{"key":"R21-20251226","first-page":"2221","article-title":"KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells.","volume":"8","author":"Zakut","year":"1993","journal-title":"Oncogene"},{"key":"R22-20251226","first-page":"6139","article-title":"Expression of c-kit receptor in normal and transformed human nonlymphoid tissues.","volume":"52","author":"Natali","year":"1992","journal-title":"Cancer Res"},{"key":"R23-20251226","first-page":"1787","article-title":"Transformation of thyroid epithelium is associated with loss of c-kit receptor.","volume":"55","author":"Natali","year":"1995","journal-title":"Cancer Res"},{"key":"R24-20251226","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1158\/1078-0432.CCR-18-0373","article-title":"Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers.","volume":"24","author":"Pozdeyev","year":"2018","journal-title":"Clin Cancer Res"},{"key":"R25-20251226","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/0929867324666171006165942","article-title":"Sunitinib in the treatment of thyroid cancer.","volume":"26","author":"Ferrari","year":"2019","journal-title":"Curr Med Chem"},{"key":"R26-20251226","first-page":"2225","article-title":"Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo.","volume":"39","author":"Ferrari","year":"2018","journal-title":"Oncol Rep"},{"key":"R27-20251226","doi-asserted-by":"crossref","first-page":"155898","DOI":"10.1016\/j.prp.2025.155898","article-title":"Curcumin enhances anti-tumor immunity in anaplastic thyroid carcinoma by elevating CD8+ T cell function and downregulating the AKT\/mTORC1\/STAT3\/PD-L1 axis.","volume":"269","author":"Zheng","year":"2025","journal-title":"Pathol Res Pract"},{"key":"R28-20251226","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1089\/thy.2024.0072","article-title":"Characterization of immune infiltrate along the leading edge of differentiated thyroid cancer.","volume":"34","author":"Kotwal","year":"2024","journal-title":"Thyroid"},{"key":"R29-20251226","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00262-025-04101-4","article-title":"Single-cell RNA sequencing and multi-omics analysis of prognosis-related staging in papillary thyroid cancer.","volume":"74","author":"Ji","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"R30-20251226","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1038\/s41596-020-0341-5","article-title":"Development of a plasma pseudotargeted metabolomics method based on ultra-high-performance liquid chromatography-mass spectrometry.","volume":"15","author":"Zheng","year":"2020","journal-title":"Nat Protoc"},{"key":"R31-20251226","doi-asserted-by":"crossref","first-page":"17666","DOI":"10.1038\/s41598-023-41176-4","article-title":"Combined metabolomic and lipidomic analysis uncovers metabolic profile and biomarkers for papillary thyroid carcinoma.","volume":"13","author":"Wang","year":"2023","journal-title":"Sci Rep"},{"key":"R32-20251226","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jamaoto.2013.5650","article-title":"Infarction of papillary thyroid carcinoma after fine-needle aspiration: case series and review of literature.","volume":"140","author":"Liu","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000046769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:24:15Z","timestamp":1785857055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000046769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":32,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046769","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"2025-06-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}